07/29/2010 Biomarkers and Clinical Trials in Parkinson’s Disease Research: Seattle, Washington, July 29, 2010
Join Deborah W. Brooks, MJFF Co-Founder, and James Leverenz, MD, of the University of Washington for a community discussion on Parkinson’s disease research.
07/20/2010 Research Roundtable in Portland, Oregon: Sunday, August 1, 2010
Join MJFF Co-Founder Deborah W. Brooks and a panel of experts in the field for an MJFF Research Roundtable for a presentation on current Parkinson's research and expert Q&A.
The Michael J. Fox Foundation has committed up to $12 million in 2011 funding for prioritized research toward transformative treatments and a cure for Parkinson’s disease.
Philanthropist Lily Safra's gift will support the Parkinson’s Progression Markers Initiative (PPMI). Mrs. Safra’s commitment will help galvanize the search for a biomarker of Parkinson’s disease progression.
07/13/2010 A $2.5 Million Gift to Chart, Conquer Parkinson's
The Wall Street Journal's "Donor of the Day" column features Mrs. Lily Safra's $2.5 million gift to MJFF to support the Parkinson's Progression Markers Initiative.
The Foundation’s Target Validation initiative, one of MJFF’s Edmond J. Safra Core Programs for PD Research, provides intellectual and financial resources to validation studies, helping to advance potential PD drug targets toward clinical trials and Parkinson’s patients.
07/07/2010 Inside Parkinson's Clinical Trials: What You Need to Know
Join an educational webinar on July 14, 2010 to learn more about participating in Parkinson's clinical trials.
07/06/2010 In New York City this July? Visit our interactive Team Fox display window at 10 Rockefeller Plaza!
The Michael J. Fox Foundation for Parkinson's Research thanks EHE International for helping raise awareness through an interactive display window in the heart of Rockefeller Center.
The discovery and validation of biomarkers is of critical importance to increasing the speed and efficiency of PD therapeutic development.
Funded investigations aim to push forward approaches that could slow or stop progression of the disease, alleviate symptoms or refine existing therapies.
06/29/2010 MJFF Announces New Web Features on PD Online Research
PD Online Research is a Web-based community of Parkinson's scientists, clinicians, health care providers, drug developers and funders who exchange ideas and information online in an effort to speed research progress.
06/23/2010 Sergey Brin's Search for a Parkinson's Cure
Sergey Brin, co-founder of Google, discusses his investments in PD research to "really move the needle". Brin is an "active and enthusiastic investor" in The Michael J. Fox Foundation.
06/22/2010 MJFF Awards $4.6 Million to Help Advance Neurotrophic Factors Research
The awards support two promising studies of neurotrophic factor therapies to help speed this avenue of research toward better treatments for people living with PD.
06/18/2010 Fourth Annual PD Therapeutics Conference: October 6, 2010
Hosted by MJFF and the New York Academy of Sciences, the PD Therapeutics Conference is the only major scientific symposium exclusively focused on speeding PD therapeutic development.
06/02/2010 MJFF's L.A. Benefit Raises Funds for Parkinson's Research
"A Sunny Thing Happened on the Way to Cure Parkinson's," held on May 26th in Beverly Hills, featured a special musical performance by Joan Jett & the Blackhearts and comedy by Greg Behrendt.
05/17/2010 Reminder: Contributions to MJFF Support Parkinson's Research, Not Political Candidates or Campaigns
Contributions made to The Michael J. Fox Foundation for Parkinson's Research support our organization's research efforts and are not used to support any political candidate or campaign.
05/14/2010 Enroll in a Clinical Trial Today to Help Speed Research Toward a Cure for PD
There is a critical need for clinical trial participants — including people with Parkinson’s and healthy individuals. Learn about SURE-PD and STEADY PD, two promising trials currently in need of volunteers.
05/04/2010 Research Roundtable in Beverly Hills: Tuesday, May 25, 2010
Join MJFF Co-Founder Deborah W. Brooks, Associate Director of Research Programs Brian Fiske, PhD, and members of the MJFF Scientific Advisory Board for a presentation on current Parkinson's research and expert Q&A.
04/30/2010 Denny's Restaurants Join the Michael J. Fox Foundation for Pancakes for Parkinson's
Denny’s events kick off in New York to support Parkinson’s disease research
04/29/2010 Biomarkers and Clinical Trials in Parkinson’s Disease Research: Thursday, June 3, in Houston
Join Deborah W. Brooks, MJFF Co-Founder, and Joseph Jankovic, MD, of Baylor College of Medicine for a community discussion on Parkinson’s disease research.
04/23/2010 MJFF Awards More Than $3 Million to Advance Parkinson's Disease Research
The funded projects complement the Foundation’s annually occurring Pipeline Programs and Critical Challenges in Parkinson’s Disease initiatives, which aim to accelerate PD therapeutic development.
04/21/2010 MJFF Launches Parkinson's Progression Markers Initiative (PPMI)
The groundbreaking, $40 million, five-year observational clinical study seeks to identify biomarkers of Parkinson’s disease.
04/16/2010 MJFF Supports Cures Acceleration Network (CAN)
As part of the health care reform bill, CAN will help speed urgently needed medical treatments to market. MJFF is one of 81 organizations that is now requesting funds to support CAN.
Join us for a community discussion on Parkinson’s disease research.
Together, Dick's Sporting Goods National Runners’ Month and Team Fox will inspire runners across the country this spring to raise awareness and funds to find a cure for Parkinson's disease.
03/23/2010 MJFF Offers High-Quality LRRK2 Antibodies for PD Therapeutic Development
MJFF is making antibodies available to Parkinson's researchers around the world at no cost.
Join MJFF CEO Katie Hood and scientists from The Institute for Neurodegenerative Disorders for a community discussion on Parkinson’s disease research.
Join MJFF Co-Founder Deborah W. Brooks and The Parkinson's Institute Scientific Director and CEO J. William Langston, MD, for a community discussion on Parkinson’s disease research.
03/08/2010 Nature Medicine Profiles MJFF's Collaborative Efforts to Advance LRRK2 Research
The LRRK2 Biology Consortium, funded by MJFF to advance understanding of the LRRK2 gene, is profiled in the March edition of Nature Medicine.
03/08/2010 Developing Improved Research Models
Nature Medicine discusses the latest technology for creating improved pre-clinical research models, including models funded by MJFF.
03/05/2010 Michael J. Fox Receives Honorary Doctorate from Karolinska Institute
Karolinska awards honorary doctorates to people who have not earned a PhD through formal academic achievements, but who have benefited research through other means.
03/02/2010 MJFF Commits up to $5.75 Million in Funding for 2010 Critical Challenges in Parkinson's Disease
Two Challenges aim to streamline efforts focused on genetic targets alpha-synuclein and LRRK2. The third will drive collaborations that maximize the resources of the Brain & Body Donation Program at the Arizona Parkinson’s Disease Consortium.
Researchers will evaluate the disease-modifying potential of transdermal nicotine using standard skin patches of the type used by millions of smokers as a quitting aid.
02/17/2010 MJFF Awards $3.5 Million to Advance LRRK2 Therapeutic Development Efforts
Using a multipronged approach that includes collaboration between the research teams, the funded projects will help advance understanding of the LRRK2 gene.
02/17/2010 Ex-NBAer Grant, Actor Fox Join Forces to Battle Parkinson's
Ex-NBAer Brian Grant's friendship with Michael J. Fox -- perhaps one of the most famous people living with Parkinson's -- has provided Grant with a compass, some sense of direction of what to do with his new life.
02/10/2010 Research Roundtable in Charlotte: Tuesday, February 23
Join MJFF CEO Katie Hood, VP of Research Programs Todd Sherer, PhD, and three leading PD researchers for a presentation on current Parkinson's research and expert Q&A in Charlotte on Tuesday evening, February 23.
Strategic investment in new research technologies and tools is critical to attaining transformative new treatments that will make a tangible impact on patients’ lives.
02/04/2010 MJFF Awards $2.8 Million to Drive Development of Parkinson's Disease Biomarker Pipeline
The discovery of PD biomarkers, physiological characteristics that can be objectively measured and evaluated by researchers, are critical to PD drug development.
Three teams will focus on inflammation and oxidative stress, two will target alpha-synuclein, and one will investigate HDACs, a family of enzymes shown to enhance expression of potential protective factors in preclinical PD models.

